Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Targeting the thioredoxin system as a novel strategy against B cell acute lymphoblastic leukemia.

Fidyt K, Pastorczak A, Goral A, Szczygiel K, Fendler W, Muchowicz A, Bartlomiejczyk MA, Madzio J, Cyran J, Graczyk-Jarzynka A, Jansen E, Patkowska E, Lech-Maranda E, Pal D, Blair H, Burdzinska A, Pedzisz P, Glodkowska-Mrowka E, Demkow U, Gawle-Krawczyk K, Matysiak M, Winiarska M, Juszczynski P, Mlynarski W, Heidenreich O, Golab J, Firczuk M.

Mol Oncol. 2019 Mar 12. doi: 10.1002/1878-0261.12476. [Epub ahead of print]

2.

GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemia.

Madzio J, Pastorczak A, Sedek L, Braun M, Taha J, Wypyszczak K, Trelinska J, Lejman M, Muszynska-Roslan K, Tomasik B, Derwich K, Koltan A, Kazanowska B, Irga-Jaworska N, Badowska W, Matysiak M, Kowalczyk J, Styczynski J, Fendler W, Szczepanski T, Mlynarski W.

Genes Chromosomes Cancer. 2019 Mar 11. doi: 10.1002/gcc.22748. [Epub ahead of print]

PMID:
30859636
3.

Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions.

Pastorczak A, Sedek L, Braun M, Madzio J, Sonsala A, Twardoch M, Fendler W, Nebral K, Taha J, Bielska M, Gorniak P, Romiszewska M, Matysiak M, Derwich K, Lejman M, Kowalczyk J, Badowska W, Niedzwiecki M, Kazanowska B, Muszynska-Roslan K, Sobol-Milejska G, Karolczyk G, Koltan A, Ociepa T, Szczepanski T, Młynarski W.

Oncotarget. 2018 May 25;9(40):25971-25982. doi: 10.18632/oncotarget.25411. eCollection 2018 May 25.

4.

Heterozygous carriers of germline c.657_661del5 founder mutation in NBN gene are at risk of central nervous system relapse of B-cell precursor acute lymphoblastic leukemia.

Tomasik B, Pastorczak A, Fendler W, Bartłomiejczyk M, Braun M, Mycko M, Madzio J, Polakowska E, Ulińska E, Matysiak M, Derwich K, Lejman M, Kowalczyk J, Badowska W, Kazanowska B, Szczepański T, Styczyński J, Irga-Jaworska N, Młynarski W; Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG).

Haematologica. 2018 May;103(5):e200-e203. doi: 10.3324/haematol.2017.181198. Epub 2018 Feb 1. No abstract available.

5.

Selected miRNA levels are associated with IKZF1 microdeletions in pediatric acute lymphoblastic leukemia.

Krzanowski J, Madzio J, Pastorczak A, Tracz A, Braun M, Tabarkiewicz J, Pluta A, Młynarski W, Zawlik I.

Oncol Lett. 2017 Sep;14(3):3853-3861. doi: 10.3892/ol.2017.6599. Epub 2017 Jul 18.

6.

Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.

Braun M, Pastorczak A, Fendler W, Madzio J, Tomasik B, Taha J, Bielska M, Sedek L, Szczepanski T, Matysiak M, Derwich K, Lejman M, Kowalczyk J, Kazanowska B, Badowska W, Styczynski J, Irga-Jaworska N, Trelinska J, Zalewska-Szewczyk B, Pierlejewski F, Wlodarska I, Młynarski W; Polish Pediatric Leukemia/Lymphoma Study Group.

Leuk Lymphoma. 2017 May;58(5):1162-1171. doi: 10.1080/10428194.2016.1228925. Epub 2016 Oct 18.

PMID:
27756164
7.

Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors.

Fendler W, Madzio J, Kozinski K, Patel K, Janikiewicz J, Szopa M, Tracz A, Borowiec M, Jarosz-Chobot P, Mysliwiec M, Szadkowska A, Hattersley AT, Ellard S, Malecki MT, Dobrzyn A, Mlynarski W.

Diabetologia. 2016 Jul;59(7):1463-1473. doi: 10.1007/s00125-016-3945-0. Epub 2016 Apr 8.

8.

Genetic variability of GCKR alters lipid profiles in children with monogenic and autoimmune diabetes.

Tracz A, Madzio J, Gnys P, Malachowska B, Borowiec M, Wyka K, Jarosz-Chobot P, Mysliwiec M, Szadkowska A, Mlynarski W, Fendler W; PolPeDiab Study Group.

Exp Clin Endocrinol Diabetes. 2014 Oct;122(9):503-9. doi: 10.1055/s-0034-1375648. Epub 2014 Jun 11.

PMID:
24918535

Supplemental Content

Loading ...
Support Center